SLC5A2 and nervous system disorder: SGLT2 receptors have been identified in the central nervous system, and a positive effect of SGLT2 inhibitors in neurological disorders has been hypothesized based on the effects of these drugs on neuron membrane potential through the modulation of sodium transport [28,29].